Center for Disease Control. Antibiotic resistance threats in the United States. Centers Dis. Control Prev. 114, 1–150 (2019).
Organization, W. Health. Global action plan on antimicrobial resistance. Microbe Mag. 10, 354–355 (2015).
CDC. Antibiotic resistance threats. Cdc 22–50 (2013).
Reed, C. et al. On the mechanism of the adjuvant effect of Bordetella pertussis vaccine. J. Allergy Clin. Immunol. 49, 174–182 (1971).
Berstad, A. K. et al. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers. J. Med. Microbiol. 49, 157–163 (2000).
Article CAS PubMed Google Scholar
Haugan, A. et al. Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines. Vaccine 22, 7–14 (2003).
Article CAS PubMed Google Scholar
Maruta, T., Oshima, M., Deitiker, P. R., Ohtani, M. & Atassi, M. Z. Use of alum and inactive Bordetella pertussis for generation of antibodies against synthetic peptides in mice. Immunol. Invest. 35, 137–148 (2006).
Article CAS PubMed Google Scholar
Aaby, P., Ravn, H. & Benn, C. S. The WHO review of the possible nonspecific effects of Diphtheria-Tetanus-Pertussis vaccine. Pediatr. Infect. Dis. J. 35, 1247–1257 (2016).
Aaby, P., Andersen, A., Ravn, H. & Zaman, K. Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO-schedule of BCG first and then DTP. A re-analysis of demographic surveillance data from rural Bangladesh. EBioMedicine 22, 173–180 (2017).
Article PubMed PubMed Central Google Scholar
Song, J.-M., Van Rooijen, N., Bozja, J., Compans, R. W. & Kang, S.-M. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc. Natl Acad. Sci. USA 108, 757–761 (2011).
Article CAS PubMed Google Scholar
Vojtek, I., Buchy, P., Doherty, T. M. & Hoet, B. Would immunization be the same without cross-reactivity? Vaccine 37, 539–549 (2019).
Agrawal, B. Heterologous immunity: role in natural and vaccine-induced resistance to infections. Front. Immunol. 10, 1–11 (2019).
Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181–193 (2011).
Article CAS PubMed PubMed Central Google Scholar
Uppuluri, P. et al. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathog. 14, 1–25 (2018).
Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326–329 (2007).
Article CAS PubMed Google Scholar
Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, 427 (2016).
Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).
Article CAS PubMed PubMed Central Google Scholar
Netea, M. G., Quintin, J. & Van Der Meer, J. W. M. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355–361 (2011).
Article CAS PubMed Google Scholar
Blok, B. A. et al. Interacting, nonspecific, immunological effects of bacille calmette-guérin and tetanus-diphtheriapertussis inactivated polio vaccinations: an explorative, randomized trial. Clin. Infect. Dis. 70, 455–463 (2020).
Zimmermann, P., Perrett, K. P., van der Klis, F. R. M. & Curtis, N. The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses. Immunol. Cell Biol. 97, 577–585 (2019).
Article CAS PubMed Google Scholar
Butkeviciute, E., Jones, C. E. & Smith, S. G. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. Future Microbiol 13, 1193–1208 (2018).
Article CAS PubMed PubMed Central Google Scholar
Bollaerts, K., Verstraeten, T. & Cohet, C. Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: assessing the potential impact of study characteristics, bias and confounding through meta-regression. Vaccine 37, 34–40 (2019).
Vaugelade, J., Pinchinat, S., Guiella, G., Elguero, E. & Simondon, F. Non-specific effects of vaccination on child survival: Prospective cohort study in Burkina Faso. Br. Med. J. 329, 1309–1311 (2004).
Belcher, T. et al. Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice. Vaccine https://doi.org/10.1016/j.vaccine.2021.01.025 (2021).
Higgins, J. P. T. et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 355, 1–13 (2016).
Sivinski, J. et al. Functional differences between E. Coli and eskape pathogen groes/groel. MBio 12, 1–16 (2021).
Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1–12 (2009).
Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis. 197, 1079–1081 (2008).
Blackwood, C. B. et al. Innate and adaptive immune responses against Bordetella pertussis and Pseudomonas aeruginosa in a murine model of mucosal vaccination against respiratory infection. Vaccines 8, 1–21 (2020).
Sen-Kilic, E. et al. Defining the mechanistic correlates of protection conferred by whole-cell vaccination against Pseudomonas aeruginosa acute murine pneumonia. Infect. Immun. https://doi.org/10.1128/iai.00451-20 (2020).
Sharma, A., Krause, A. & Worgall, S. Recent developments for Pseudomonas vaccines. Hum. Vacc. https://doi.org/10.4161/hv.7.10.16369 (2011).
Priebe, G. P. & Goldberg, J. B. Vaccines for Pseudomonas aeruginosa: a long and winding road. Expert Rev. Vaccines 13, 507–519 (2014).
Article CAS PubMed PubMed Central Google Scholar
Zhou, Z. et al. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J. Cyst. Fibros. https://doi.org/10.1016/S1569-1993(11)60021-0 (2011).
Jensen, P., Johansen, H. K., Lanng, S. & HØiby, N. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Pediatr. Res. 49, 423–428 (2001).
Article CAS PubMed Google Scholar
Woo, P. C. Y., Leung, P. K. L., Wong, S. S. Y., Ho, P. L. & Yuen, K. Y. groEL encodes a highly antigenic protein in Burkholderia pseudomallei. Clin. Diagn. Lab. Immunol. 8, 832–836 (2001).
Article CAS PubMed PubMed Central Google Scholar
Bochkareva, E. S., Solovieva, M. E. & Girshovich, A. S. Targeting of GroEL to SecA on the cytoplasmic membrane of Escherichia coli. Proc. Natl Acad. Sci. USA 95, 478–483 (1998).
Article CAS PubMed PubMed Central Google Scholar
Charbona, G. et al. Localization of GroEL determined by in vivo incorporation of a fluorescent amino acid. Bioorg. Med. Chem. Lett. 21, 6067–6070 (2011).
Fayet, O., Ziegelhoffer, T. & Georgopoulos, C. The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures. J. Bacteriol. 171, 1379–1385 (1989).
Burns, J. L. et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183, 444–452 (2001).
Article CAS PubMed Google Scholar
Lin, Z., Madan, D. & Rye, H. S. GroEL stimulates protein folding through forced unfolding Zong. Nat. Struct. Mol. Biol. 15, 303–311 (2003).
Sipos, A., Klocke, M. & Frosch, M. Cloning and sequencing of the genes coding for the 10- and 60-kDa heat shock proteins from Pseudomonas aeruginosa and mapping of a species-specific epitope. Infect. Immun. 59, 3219–3226 (1991).
Article CAS PubMed PubMed Central Google Scholar
Pané-Farré, J., Quin, M. B., Lewis, R. J. & Marles-Wright, J. Macromolecular Protein Complexes. Sub-Cellular Biochemistry Vol. 83 (2017).
Woo, P. C. Y., Leung, P. K. L. & Wong, S. S. Y. groEL encodes a highly antigenic protein in Burkholderia pseudomallei. 8, 832–836 (2001).
Raeven, R. H. M. et al. Antibody specificity following a recent Bordetella pertussis infection in adolescence is correlated with the pertussis vaccine received in childhood. Front. Immunol. 10, 1364 (2019).
Article CAS PubMed PubMed Central Google Scholar
Chitradevi, S. et al. Recombinant heat shock protein 60 (GroEL) of S. Typhi as an effective adjuvant in modulating the immunogenicity of Invasion plasmid antigen B (IpaB) of Shigella flexneri against lethal Shigella infection in mice. Cell. Mol. Immunol. 4, 7560 (2013).
Pechine, S., Hennequin, C., Hoys, S. & Collignon, A. Immunization using GroEL decreases clostridium difficile intestinal colonization. PLoS One. 8, 1–9 (2013).
Török, Z. et al. Evidence for a lipochaperonin: association of active protein-folding GroESL oligomers with lipids can stabilize membranes under heat shock conditions. Proc. Natl Acad. Sci. USA 94, 2192–2197 (1997).
Article PubMed PubMed Central Google Scholar
Huittinen, T. et al. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler. Thromb. Vasc. Biol. 22, 431–437 (2002).
Article CAS PubMed Google Scholar
Confer, A. W. & Ayalew, S. The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Vet. Microbiol. 163, 207–222 (2013).
留言 (0)